G6PD and Parkinson disease: In addition to difference in sample size, examined materials (RBC, leukocyte, neuronal cell lines, human/mouse brain tissues), measurement methods/sensitivity, and disease stage/severity, dynamic changes in the activity of G6PD in different stages of PD might also contribute to the significant heterogeneity among studies [13, 20, 21].